1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. AVALO THERAPEUTICS INC
Avalo Therapeutics Inc XNAS: AVTX
15.65 -0.10 (-0.63%)
224.2K
XNAS Volume

XNAS 26 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert

Avalo Therapeutics Inc - AVTX - stock price prediction, stock price target, analyst ratings from 10 analysts

Avalo Therapeutics Inc has a share price target of US$ 34 and profit growth estimate of -139.0% for Unknown Year, based on top 10 analyst calls.